Anticorps Monoclonal anti-NeutraKine® IL-4
NeutraKine® IL-4 Monoclonal Antibody for Neutralization, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
Neutralization, ELISA
Conjugaison
Non conjugué
CloneNo.
1H5G5
N° de cat : 69005-1-Ig
Synonymes
Galerie de données de validation
Neutralization |
Informations sur le produit
69005-1-Ig cible NeutraKine® IL-4 dans les applications de Neutralization, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | human Humankine IL-4 protein HZ-1004 |
Nom complet | interleukin 4 |
Symbole du gène | IL4 |
Identification du gène (NCBI) | 3565 |
Conjugaison | Non conjugué |
Forme | Lyophilized Powder |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS stérile. |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Informations générales
IL4 is a cytokine produced by CD4+ T cells in response to helminthes and other extracellular parasites. It promotes the proliferation and differentiation of antigen presenting cells. IL4 also plays a pivotal role in antibody isotype switching and stimulates the production of IgE. This cytokine has been applied in the treatment of autoimmune disorder like multiple myeloma, cancer, psoriasis, and arthritis. IL4 has also been extensively applied to inhibit detrimental effect of Th1. It may promote the growth of epithelial tumors by mediating increased proliferation and survival.
This antibody can be used to neutralize the bioactivity of IL-4.